NDC 71335-3073 – Ondansetron

Ondansetron 8 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC71335-3073

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA090469
Marketed since
April 12, 2010
Listing expires
December 31, 2027
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (10)

Package NDCDescriptionSince
71335-3073-014 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-0)Feb 9, 2026
71335-3073-130 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-1)Feb 9, 2026
71335-3073-210 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-2)Feb 9, 2026
71335-3073-39 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-3)Feb 9, 2026
71335-3073-45 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-4)Feb 9, 2026
71335-3073-53 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-5)Feb 9, 2026
71335-3073-66 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-6)Feb 9, 2026
71335-3073-712 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-7)Feb 9, 2026
71335-3073-84 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-8)Feb 9, 2026
71335-3073-920 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-3073-9)Feb 9, 2026

Other Ondansetron products